Comparative effects of nonsedating histamine H 1 receptor antagonists, ebastine and terfenadine, on human Kv1.5 channels

By Valenzuela C.   Delpon E.   Franqueza L.   Gay P.   Vicente J.   Tamargo J.  

European Journal of Pharmacology, Vol. 326, Iss. 2, 1997-05 ,pp. : 257-263

Elsevier

Access to resources Recommend Favorite

Pharmacological properties of -mangostin, a novel histamine H 1 receptor antagonist

By Chairungsrilerd N.   Furukawa K.-I.   Ohta T.   Nozoe S.   Ohizumi Y.  

European Journal of Pharmacology, Vol. 314, Iss. 3, 1996-10 ,pp. : 351-356

Elsevier

Access to resources Recommend Favorite

Serum protein binding of histamine H 1 -antagonists A comparative study on the serum protein binding of a sedating ([ 3 H]mepyramine) and a non-sedating H 1 -antagonist ([ 3 H]loratadine).

By ter Laak A.M.   Bijloo G.J.   Fischer M.J.E.   op den Kelder G.M.D.   Wilting J.   Timmerman H.  

European Journal of Pharmaceutical Sciences, Vol. 4, Iss. 5, 1996-09 ,pp. : 307-319

Elsevier

Access to resources Recommend Favorite

Histamine H1 receptor antagonists: Enhancement of ST segment changes (first reports with homochlorcyclizine, fexofenadine, epinastine and dexchlorpheniramine) in a patient with Brugada syndrome: case report

By  

Reactions Weekly, Vol. 1, Iss. 1265, 2009-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

Lead Optimization of Melanin Concentrating Hormone Receptor 1 Antagonists with low hERG Channel Activity

By  

Current Topics in Medicinal Chemistry, Vol. 8, Iss. 13, 2008-01 ,pp. : 1152-1157

Bentham Science Publishers

Access to resources Recommend Favorite